Bastiaannet Remco, Lodge Martin A, de Jong Hugo W A M, Lam Marnix G E H
Department of Radiology and Nuclear Medicine, University Medical Center, Huispost E01.132, Postbus 85500, Utrecht 3508 GA, Netherlands; The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, 601 N. Caroline St., Baltimore, MD 21287, USA.
The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, 601 N. Caroline St., Baltimore, MD 21287, USA.
PET Clin. 2019 Oct;14(4):447-457. doi: 10.1016/j.cpet.2019.06.002. Epub 2019 Jul 31.
Recent research into the efficacy of radioembolization has brought this field to an interesting position, in which fluorodeoxyglucose (FDG)-PET/CT is being used extensively for prognosis and response assessment, as well as a tool to define viable tumor volumes for the use in dosimetry. As such, there is an overlap with existing techniques used in radiotherapy; however, many are very specific to the radioembolization paradigm. This article describes the current state-of-the-art of the use of FDG-PET/CT for patient selection, prognosis, treatment evaluation, and as a research tool into absorbed dose-response relationships in radioembolization.
近期关于放射性栓塞疗效的研究使该领域处于一个有趣的境地,即氟脱氧葡萄糖(FDG)-PET/CT被广泛用于预后和反应评估,以及作为确定用于剂量测定的存活肿瘤体积的工具。因此,它与放射治疗中使用的现有技术存在重叠;然而,许多技术是放射性栓塞模式所特有的。本文介绍了FDG-PET/CT在放射性栓塞患者选择、预后、治疗评估以及作为吸收剂量-反应关系研究工具方面的当前技术水平。